Tradestie Institutional Equity Comparison Engine
BSLK vs VTAK โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
VTAK Overall Edge
VTAK Captures Institutional Edge (2โ1 Pillars ยท 4โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Catheter Precision, Inc. (VTAK) driven by superior Growth & Margin, Momentum & Technical while BSLK counters with relative strength in Valuation. Fundamentally, BSLK trades at N/M Forward P/E with -1179.5% operating margin (+7300.0% YoY revenue) versus VTAK at N/M Forward P/E and -388.1% operating margin (+380.7% YoY). In options structure, BSLK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against VTAK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
BSLK
BSLK N/M vs VTAK N/M Fwd P/E
Growth & Margin Winner
VTAK
Op Margin -1179.5% vs -388.1% ยท YoY +7300.0% vs +380.7%
Momentum & Technical Winner
VTAK
1Y -94.4% vs -94.3% ยท 52W Pos 0% vs 1%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BSLK
NASDAQ
Bolt Projects Holdings, Inc. Common Stock
Industrial Organic Chemicals
$0.58
-27.01% 1D
Market Cap
$7.1M
1M Return
-73.85%
1Y Return
-94.42%
Forward P/E
N/M
Unified AI Score
41.2 / 100
SELL
Tech 40.0
Fund 43.0
Flow 50.0
Mom 40.0
VTAK
NYSE American
Catheter Precision, Inc.
Surgical & Medical Instruments & Apparatus
$0.15
-0.66% 1D
Market Cap
$548,639
1M Return
-24.76%
1Y Return
-94.28%
Forward P/E
N/M
Unified AI Score
58.1 / 100
HOLD
Tech 72.0
Fund 70.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BSLK -94.42%
VTAK -94.28%
Spread: +62.22 pp (VTAK Lead)
Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)
| Period | BSLK Revenue | VTAK Revenue | BSLK Op. Margin | VTAK Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| Q1 '25 | $0M | $0M | -3157.9% | -2416.8% | VTAK |
| Q2 '25 | $10M | $0M | -370.0% | -1338.7% | BSLK |
| Q3 '25 | $0M | $0M | -1179.5% | -1336.7% | BSLK |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BSLK | VTAK | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $7.1M | $548,639 | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | 0.1x | N/M | Lower Multiple | BSLK |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +7300.0% | +380.7% | Higher Growth | BSLK |
| Operating Margin (TTM) Profitability | -1179.5% | -388.1% | Higher Margin | VTAK |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -4288.3% | -111.3% | Higher ROE | VTAK |
| 52-Week Range Position Momentum | 0% ($1โ$25) | 1% ($0โ$3) | Stronger Trend | Tie |
| Beta / 30D Volatility Risk Regime | 4.04ฮฒ ยท 148% Vol | 0.19ฮฒ ยท 76% Vol | Lower Realized Risk | VTAK |
| Unified Institutional Score Composite Signal | 41.2 / 100 (SELL) | 58.1 / 100 (HOLD) | Higher Composite | VTAK |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BSLK vs VTAK Buy Guide
BSLK
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
VTAK
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BSLK nor VTAK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.